153 related articles for article (PubMed ID: 38454119)
21. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
22. Prognosis and treatment of Waldenström's macroglobulinemia.
Louw VJ; Webb MJ
Transfus Apher Sci; 2010 Apr; 42(2):193-7. PubMed ID: 20117052
[TBL] [Abstract][Full Text] [Related]
23. Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia.
Alfaraj WA; Cachia D; Tummala S; Thomas SK; Manasanch EE
Ann Hematol; 2016 Jan; 95(2):347-8. PubMed ID: 26432713
[No Abstract] [Full Text] [Related]
24. Treatment for Waldenstrom's macroglobulinemia.
Chen CI
Ann Oncol; 2004 Apr; 15(4):550-8. PubMed ID: 15033658
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
Dimopoulos MA; Tsatalas C; Zomas A; Hamilos G; Panayiotidis P; Margaritis D; Matsouka C; Economopoulos T; Anagnostopoulos N
Semin Oncol; 2003 Apr; 30(2):265-9. PubMed ID: 12720150
[TBL] [Abstract][Full Text] [Related]
26. Current and future therapeutic approach for Waldenström's macroglobulinemia.
Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
[TBL] [Abstract][Full Text] [Related]
27. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
Carella AM
Haematologica; 1990; 75(6):581. PubMed ID: 1711503
[No Abstract] [Full Text] [Related]
28. Effect of chemotherapy schedule on response in Waldenström's macroglobulinemia in a dog.
Greenberg CB; Boria PA; Raskin RE; Lucroy MD
J Vet Intern Med; 2008; 22(1):223-6. PubMed ID: 18289314
[No Abstract] [Full Text] [Related]
29. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy].
Baldus M; Brass H
Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477
[No Abstract] [Full Text] [Related]
30. [Waldenström's macroglobulinemia. Current developments in diagnostics and therapy].
Grunenberg A; Buske C
Internist (Berl); 2016 Mar; 57(3):238-44. PubMed ID: 26830425
[TBL] [Abstract][Full Text] [Related]
31. Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
Herth I; Hensel M; Rieger M; Horstmann K; Hiddemann W; Dreyling M; Koniczek S; Witzens-Harig M; Ho AD
Leuk Lymphoma; 2015 Jan; 56(1):97-102. PubMed ID: 24724778
[TBL] [Abstract][Full Text] [Related]
32. Assessment of bone marrow response in Waldenström's macroglobulinemia.
Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
[TBL] [Abstract][Full Text] [Related]
33. Optic nerve involvement of Waldenström's macroglobulinemia: with autopsy findings.
Nishida H; Hashida R; Hatano M; Hori M; Obara K
Neurol Sci; 2014 Aug; 35(8):1299-302. PubMed ID: 25027010
[TBL] [Abstract][Full Text] [Related]
34. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
35. [Waldenström's macroglobulinemia with immunocytoma of the lung].
Fuchs P; Fontana A; Sulser H
Schweiz Med Wochenschr; 1977 Jan; 107(3):84-7. PubMed ID: 402022
[TBL] [Abstract][Full Text] [Related]
36. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Dimopoulos MA; Trotman J; Tedeschi A; Matous JV; Macdonald D; Tam C; Tournilhac O; Ma S; Oriol A; Heffner LT; Shustik C; García-Sanz R; Cornell RF; de Larrea CF; Castillo JJ; Granell M; Kyrtsonis MC; Leblond V; Symeonidis A; Kastritis E; Singh P; Li J; Graef T; Bilotti E; Treon S; Buske C;
Lancet Oncol; 2017 Feb; 18(2):241-250. PubMed ID: 27956157
[TBL] [Abstract][Full Text] [Related]
37. Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature.
Delgado J; Canales MA; Garcia B; Alvarez-Ferreira J; Garcia-Grande A; Hernandez-Navarro F
Am J Hematol; 2002 Feb; 69(2):127-31. PubMed ID: 11835349
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcgammaRIIa polymorphism.
Poulain S; Dervite I; Leleu X; Fernandes J; Stalnikiewicz L; Moreau AS; Coiteux V; de Botton S; Duthilleul P; Morel P
Leukemia; 2006 Jun; 20(6):1179-81. PubMed ID: 16598310
[No Abstract] [Full Text] [Related]
39. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
Amin CJ; Rabinowitz I
Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
[TBL] [Abstract][Full Text] [Related]
40. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
Pilon AF; Rhee PS; Messner LV
Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
